Cytoprotective effect of imatinib mesylate in non-BCR-ABL-expressing cells along with autophagosome formation

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 310-315

  Ohtomo, Tadashi ^a   Miyazawa, Keisuke ^a   Naito, Munekazu ^a   Moriya, Shota ^a   Kuroda, Masahiko ^a   Itoh, Masahiro ^a   Tomoda, Akio ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Autophagy; Chronic myelogenous leukemia; ER stress; Imatinib mesylate; Tyrosine kinase inhibitor

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; CYTARABINE; IMATINIB; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATTENUATION; AUTOPHAGY; CANCER CELL CULTURE; CELL COUNT; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELL VIABILITY; CYTOTOXICITY; DRUG EFFECT; ELECTRON MICROSCOPY; EMBRYO; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL LINE, TUMOR; CYTOPROTECTION; FUSION PROTEINS, BCR-ABL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PHAGOSOMES; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; REACTIVE OXYGEN SPECIES;

MURINAE;

EID: 72949097628     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.055     Document Type: Article

References (25)

1. Druker B.J., Tamura S., Buchdunger E., Ohno S., Segal G.M., Fanning S., Zimmermann J., and Lydon N.B. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 2 (1996) 561-566
2. Demetri G.D., von Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., Heinrich M.C., Tuveson D.A., Singer S., Janicek M., Fletcher J.A., Silverman S.G., Silberman S.L., Capdeville R., Kiese B., Peng B., Dimitrijevic S., Druke B.J., Corless C., Fletcher C.D., and Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347 (2002) 472-480
3. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C., Tefferi A., Malone J., Alam R., Schrier S.L., Schmid J., Rose M., Vandenberghe P., Verhoef G., Boogaerts M., Wlodarska I., Kantarjian H., Marynen P., Coutre S.E., Stone R., and Gilliland D.G. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med. 348 (2003) 1201-1214
4. Druker B.J., Guilhot F., O'Brien S.G., Gathmann I., Kantarjian H., Gattermann N., Deininger M.W., Silver R.T., Goldman J.M., Stone R.M., Cervantes F., Hochhaus A., Powell B.L., Gabrilove J.L., Rousselot P., Reiffers J., Cornelissen J.J., Hughes T., Agis H., Fischer T., Verhoef G., Shepherd J., Saglio G., Gratwohl A., Nielsen J.L., Radich J.P., Simonsson B., Taylor K., Baccarani M., So C., Letvak L., and Larson R.A. IRIS Investigator, five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med. 355 (2006) 2408-2417
5. Levine B., and Kroemer G. Autophagy in the pathogenesis of disease. Cell 132 (2008) 27-42
6. Mizushima N. Physiological functions of autophagy. Curr. Top. Microbiol. Immunol. 335 (2009) 71-84
7. Ertmer A., Huber V., Gilch S., Yoshimori T., Erfle V., Duyster J., Elsässer H.P., and Schätzl H.M. The anticancer drug imatinib induces cellular autophagy. Leukemia 21 (2007) 936-942
8. Bellodi C., Lidonnici M.R., Hamilton A., Helgason G.V., Soliera A.R., Ronchetti M., Galavotti S., Young K.W., Selmi T., Yacobi R., Van Etten R.A., Donato N., Hunter A., Dinsdale D., Tirrò E., Vigneri P., Nicotera P., Dyer M.J., Holyoake T., Salomoni P., and Calabretta B. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119 (2009) 1109-1123
9. Louvet C., Szot G.L., Lang J., Lee M.R., Martinier N., Bollag G., Zhu S., Weiss A., and Bluestone J.A. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 105 (2008) 18895-18900
10. Yokoyama T., Miyazawa K., Naito M., Toyotake J., Tauchi T., Itoh M., Yuo A., Hayashi Y., Georgescu M.N., Kondo Y., Kondo S., and Ohyashiki K. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy 4 (2008) 629-640
11. Hosokawa N., Hara Y., and Mizushima N. Generation of cell lines with tetracycline-regulated autophagy and a role for autophagy in controlling cell size. FEBS Lett. 580 (2006) 2623-2639
12. Fang G., Kim C.N., Perkins C.L., Ramadevi N., Winton E., Wittmann S., and Bhalla K.N. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood 96 (2000) 2246-2253
13. Takeshige K., Baba M., Tsuboi S., Noda T., and Ohsumi Y. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J. Cell. Biol. 119 (1992) 301-311
14. Togalingam G., and Pnedergast M. Abl kinases regulates autophagy by promoting the trafficking and function of lysosomal components. J. Biol. Chem. 283 (2008) 35941-35953
15. Mizushima N., and Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 3 (2007) 542-545
16. Sarkar S., Davies J.E., Huang Z., Tunnacliffe A., and Rubinsztein D.C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 282 (2007) 5641-5652
17. Pan T., Rawal P., Wu Y., Xie W., Jankovic J., and Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience (2009) (Epub ahead of print)
18. Moscat J., and Diaz-Meco M.T. P62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137 (2009) 1001-1004
19. Kirkin V., McEwan D.G., Novak I., and Dikic I. A role for ubiquitin in selective autophagy. Mol. Cell 34 (2009) 259-269
20. Abeliovich H. Mitophagy: the life-or-death dichotomy includes yeast. Autophagy 3 (2007) 275-277
21. Kraft C., Deplazes A., Sohrmann M., and Peter M. Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease. Nat. Cell Biol. 10 (2008) 602-610
22. Bernales S., Schuck S., and Walter P. ER-phagy: selective autophagy of the endoplasmic reticulum. Autophagy 3 (2007) 285-287
23. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., and Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12 (1998) 982-995
24. Han M.S., Chung K.W., Cheon H.G., Rhee S.D., Yoon C.H., Lee M.K., Kim K.W., and Lee M.S. Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice. Diabetes 58 (2009) 329-336
25. Wang J.Y.J. Regulation of cell death by the Abl tyrosine kinase. Oncogene 19 (2000) 5643-5650